Skip to main content
Arizona Watch· Daily Pulse

Arizona's 2026 Settlement Naloxone Pipeline: 40,000 Units Confirmed for September Delivery

Hikma and Amneal settlement allotments — plus the AG's separate 55,000-unit county distribution — give Arizona a defined naloxone supply pipeline through 2029, but timing concentrates the first wave around September.

ByThe Rize NewsroomMay 21, 20261 min readOpioids

Arizona’s 2026 Settlement Naloxone Pipeline

What happened

Arizona’s settlement-funded naloxone pipeline for 2026 is now defined enough to plan against. AHCCCS confirms that the Hikma settlement will deliver 6,599 units of nasal naloxone (each unit = 2 doses) for September 2026 shipment — the first-order deadline was March 24. The Amneal settlement adds 33,714 units over four years beginning in 2026, with the first 8,428 units also targeting a September shipment. Separately, AG Kris Mayes announced 55,000 units distributed to county health departments through a different settlement channel.

Why it matters

These three streams sit on top of the broader One Arizona Agreement ($1.215B over 18 years; 56% to counties and cities, 44% to the state). The practical implication for organizations distributing naloxone in Arizona: there is a defined pipeline through at least 2029, but a meaningful share of the 2026 supply concentrates around a single September delivery window. Programs planning summer outreach should not assume the supply situation will look the same in August as it does in October.

What we’re watching

Whether the state publishes a county-level allocation breakdown for the September shipments before they arrive — Maricopa, Pima, Yavapai, Coconino, Pinal — and whether the recent SAMHSA guidance restricting federal funds for harm-reduction supplies shifts which programs have the operational capacity to receive and distribute these units when they land.

Sources: AHCCCS · AZ Attorney General · Maricopa County Opioid Settlement Planning

Filed Under

policyharm-reductionNaloxoneOpioid SettlementHarm Reduction

Continue reading

More from this section